Elysium Health

Series-B
elysiumhealth.com Biotech & Healthcare
Total Funding $40M
Latest Round $40M Series-B
Last Announced Oct 24, 2026
Investors Undisclosed
Decision Makers 6 Available

About Elysium Health

Elysium creates clinically proven longevity supplements developed with world-leading scientists. Target cellular health with research-backed healthy aging supplements.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters Undisclosed
Tracked Since Oct 24, 2026

Web & Domain Identity

Official Website elysiumhealth.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @companies
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $40,000,000 · Series-B

    news.google.com

  2. Capital Raise

    Series-B announced

    fundraisingfox.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Elysium Health.

Funding History

2 Rounds
Series-B equity · Oct 24, 2026
$40,000,000 news.google.com
Series-B equity · Apr 3, 2026

Founders & Leadership

3

Dan Alminana

co-founder

Work email & phone locked Unlock →

Eric Marcotulli

co-founder

Work email & phone locked Unlock →

Leonard Guarente

co-founder and chief scientist

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts